STRO Stock Summary and Trading Ideas (Sutro Biopharma | NASDAQ:STRO)

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

What symbol and exchange does Sutro Biopharma shares trade?

Sutro Biopharma trades on the NASDAQ stock market under the symbol STRO.

What is Sutro Biopharma stock price doing today?

As of October 2, 2026, STRO stock price declined to $15.35 with 359,291 million shares trading.

What is Sutro Biopharma's Beta?

STRO has a beta of 2.53, meaning it tends to be more sensitive to market movements. STRO has a correlation of 0.11 to the broad based SPY ETF.

How much is Sutro Biopharma worth?

STRO has a market cap of $254.31 million. This is considered a Small Cap stock.

How much money does Sutro Biopharma make?

Last quarter Sutro Biopharma reported $10 million in Revenue and -$2.33 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.11.

What is the highest and lowest price Sutro Biopharma traded in the last 3 year period?

In the last 3 years, STRO traded as high as $61.30 and as low as $5.23.

What are the top ETFs holding Sutro Biopharma?

The top ETF exchange traded funds that STRO belongs to (by Net Assets): VTI, IWM, VXF, FESM, VTWO.

Is Sutro Biopharma (STRO) a good investment?

STRO has outperformed the market in the last year with a return of +70.1%, while the SPY ETF gained +16.1%. However, in the most recent history, STRO shares have underperformed the stock market with its stock returning -49.6% in the last 3 month period and +0.1% for the last 2 week period, while SPY has returned +3.6% and +1.0%, respectively.

What are the support and resistance levels for Sutro Biopharma (STRO)?

STRO support price is $15.24 and resistance is $16.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that STRO shares will trade within this expected range on the day.